HSINCHU, 18 de maio de 2023 /PRNewswire/ — A fabricação inteligente e um rigoroso controle de processos melhoram a qualidade do TPU. A ICP DAS – BMP (Polímeros Biomédicos), uma fornecedora de TPU (poliuretano termoplástico) de classe médica sediada em Taiwan, é uma empresa pioneira que implementa sistemas de IIoT em uma fábrica inteligente para … Read more
HSINCHU, May 18, 2023 /PRNewswire/ — Smart manufacturing & stringent process control enhance TPU quality. ICP DAS – BMP (Biomedical Polymers), a Taiwan-based supplier of medical-grade TPU (thermoplastic polyurethane), acts as a front-runner who deploys IIoT systems in a smart factory to maintain lot-to-lot consistency in TPU production. The company will showcase its prime quality … Read more
TAIZHOU, China, May 17, 2023 /PRNewswire/ — Jiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that, MSCI announced the results of the semi-annual review of the MSCI Global Small Cap Indexes on May 12, 2023, and the Company has been selected as a constituent of the … Read more
SHENZHEN, China, 15. Mai 2023 /PRNewswire/ — MGI Tech Co. Ltd. (MGI), ein Unternehmen, das sich dem Aufbau von Kerninstrumenten und Technologien zur Führung der LEAD Life Science verschrieben hat, teilte kürzlich mit, dass im Rahmen des offiziell in ARM 2019 auf den Markt gebrachten „Million Microbiome of Humans Project (MMHP)” insgesamt 60.000 Proben unter … Read more
YANGZHOU, China, May 15, 2023 /PRNewswire/ — Meihua International Medical Technologies Co., Ltd. (“MHUA” or the “Company”) (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that its wholly-owned subsidiary, Jiangsu Huadong Medical Device Industrial Co., Ltd. (“Jiangsu Huadong”), has been invited … Read more
SHENZHEN, China, May 15, 2023 /PRNewswire/ — MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, recently shared that a total of nearly 60,000 samples have been sequenced among 21 institutes and over 10 participating nations throughout Europe, as part of the Million Microbiome of Humans … Read more
JINAN, China, 12. Mai 2023 /PRNewswire/ — Am 8. Mai 2023 veröffentliche das Journal of Hematology & Oncology (JHO, 2022 Impact Factor von 23.168) die Ergebnisse der klinischen Phase-I-Studie des bifunktionalen Immuntherapie-Antikörpers QL1706 von Qilu Pharma (J Hematol Oncol 8. Mai 2023;16(1):50). Diese Studie ist die erste große klinische Phase-I-Studie mit QL1706 am Menschen und … Read more
-Resultados del estudio clínico de fase I del anticuerpo bifuncional PD-1/CTLA-4 Iparomlimab/Tuvonralimab de Qilu Pharma publicado en línea en Journal of Hematology & Oncology JINAN, China, 12 de mayo de 2023 /PRNewswire/ — El 8 de mayo de 2023, Journal of Hematology & Oncology (JHO, 2022 factor de impacto de 23.168) publicó los resultados del … Read more
JINAN, China, May 12, 2023 /PRNewswire/ — On May 8, 2023, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma’s immunotherapy bifunctional antibody, QL1706 (J Hematol Oncol. 2023 May 8;16(1):50). This study is the first large Phase I clinical trial of … Read more
─Reported Top-line Results from CM-101 Phase 2 Liver Fibrosis Trial in NASH Patients Demonstrating Safety and Positive Activity Across Multiple Fibrotic and Inflammatory Biomarkers─ ─Received FDA Clearance for CM-101 Systemic Sclerosis IND—Phase 2 Trial Expected to Open Mid-year─ ─Advancing Phase 2 PSC Trial and Enrolling Patients in Higher Dose Cohort ─ ─Extending Estimated Cash Runway … Read more